Molecular lipophilicity in protein modeling and drug design.
about
A systematic framework for molecular dynamics simulations of protein post-translational modificationsNovel lynx spider toxin shares common molecular architecture with defense peptides from frog skinSequential application of ligand and structure based modeling approaches to index chemicals for their hH4R antagonismMicroscopic analysis of protein oxidative damage: effect of carbonylation on structure, dynamics, and aggregability of villin headpieceModular organization of α-toxins from scorpion venom mirrors domain structure of their targets, sodium channels.The membrane-proximal fusion domain of HIV-1 GP41 reveals sequence-specific and fine-tuning mechanism of membrane binding.The performance of 1-ethyl-3-methylimidazolium tetrafluoroborate ionic liquid as mobile phase additive in HPLC-based lipophilicity assessment.Computational study of the human dystrophin repeats: interaction properties and molecular dynamics.Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitorsLipid-II forms potential "landing terrain" for lantibiotics in simulated bacterial membrane.Evidence for water-tuned structural differences in proteins: an approach emphasizing variations in local hydrophilicity.Impact of hapten presentation on antibody binding at lipid membrane interfacesPeptides and metallic nanoparticles for biomedical applications.Protein Electrostatic Properties Predefining the Level of Surface Hydrophobicity Change upon Phosphorylation.Analogue encoding of physicochemical properties of proteins in their cognate messenger RNAs.High-Affinity α-Conotoxin PnIA Analogs Designed on the Basis of the Protein Surface Topography Method.Hydrophobicity--shake flasks, protein folding and drug discovery.Chemodiversity and molecular plasticity: recognition processes as explored by property spaces.Advances in visual representation of molecular potentials.Computational analysis of the glutamate receptor gene family of Arabidopsis thaliana.Aromatic interactions at the ligand-protein interface: Implications for the development of docking scoring functions.Pharmacophore Mapping Approach for Drug Target Identification: A Chemical Synthesis and in Silico Study on Novel Thiadiazole Compounds.Anti-trypanosomal activities and structural chemical properties of selected compound classes.Receptor-Guided De Novo Design of Dengue Envelope Protein Inhibitors.3D hydrophobic moment vectors as a tool to characterize the surface polarity of amphiphilic peptides.Structural Insight into Specificity of Interactions between Nonconventional Three-finger Weak Toxin from Naja kaouthia (WTX) and Muscarinic Acetylcholine Receptors.Temperature-sensitive gating of TRPV1 channel as probed by atomistic simulations of its trans- and juxtamembrane domains.Sequence signatures of direct complementarity between mRNAs and cognate proteins on multiple levels.Docking simulation and competitive experiments validate the interaction between the 2,5-xylidine inhibitor and Rigidoporus lignosus laccase.N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins.A Fragment-Based Scoring Function to Re-rank ATP Docking Results.Analysis of hydrophobic interactions of antagonists with the beta2-adrenergic receptor.Nature is the best source of anti-inflammatory drugs: indexing natural products for their anti-inflammatory bioactivity.PREDDIMER: a web server for prediction of transmembrane helical dimers.Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis.Synthesis and anti-inflammatory activity of new alkyl-substituted phthalimide 1H-1,2,3-triazole derivatives.PLATINUM: a web tool for analysis of hydrophobic/hydrophilic organization of biomolecular complexes.Ligand-specific scoring functions: improved ranking of docking solutions.
P2860
Q21145303-AFFD7D42-116E-42A6-82DB-4110A5E81F45Q27674326-739D1AFC-CEB6-4737-BF02-BBAD690DA3D7Q28543874-6B53CDD1-13C6-4351-B9EA-B5A063987E89Q30402013-C89288B7-09CE-4A9D-B019-7602F3A2B0C5Q30430009-1B311292-3961-48F2-9035-5782AFD0290CQ31122565-558442C5-D992-463B-B60C-E37CA79308C1Q33673038-B7009EC5-6FB3-4F20-BA8C-1533C7002A03Q34013751-702D2D7D-65B9-49A7-96C6-0748D23BEE48Q34299161-D883901E-4E45-4407-B726-F83C1A1C068CQ34339406-B601EA1D-5D5A-441C-8564-434B5597F906Q34438315-FF47144E-C8B5-4B9D-8ED3-C00DB8302A87Q36510528-1560C11B-2BB1-4B6F-9B81-CF7C8825E432Q36918020-52F4BDE4-F55A-4B65-9037-3B1B4E627332Q37053147-43044ED4-1F76-4A05-822B-E31E8F0A581EQ37403881-45B069AC-9BDC-40DF-A879-480BD3A44C63Q37411892-FBA6440E-46A0-40AC-B78B-2DEFBA91FFD2Q37636267-BC9E37E8-7B72-4A7F-85C1-268E484096D2Q37894716-BD8E7EF2-0FDF-49E7-ABFD-F4C2C98B1F81Q38028553-F1CF7BA1-2C55-4C34-94AD-DAD07DAA553DQ38442739-83DC4C37-32B0-45AB-B2BF-DDBE3784A135Q38620756-B8D9B49B-29CE-493A-BC8E-7EDCB9819099Q38704262-ADD4CCFE-DE7C-455F-BAFA-2DC2DA1BFC2BQ38938547-ABA6B97C-A53D-4D56-A658-953202D575E9Q40142168-061B509A-29EA-4470-9E05-706AF40D99B2Q40537362-603BF998-B6F1-4CDA-8840-CC2748452224Q40660620-4329640C-3DC0-4B49-B1A5-39AC3FB53105Q41052388-6037F289-C041-42EB-8D48-14C3122BB96CQ41884903-9D47068F-54AB-4E2C-BFAB-E28D4EC7C4B6Q43241420-8922B2AB-A669-48F2-B7D5-EE7BF4078449Q45516984-683D083E-B73D-42BA-B95A-52DE479474F5Q45777298-AEB616DE-BC29-47D1-8165-25CEB5504C97Q46471725-71B652BA-FCB2-4208-84F3-73D7383B27EBQ47669014-FEADC4B7-276E-457D-A28A-2242F72C331DQ51143792-270559C9-AAD1-4B43-9792-26BB2A1D912CQ51370621-88D35528-7A2A-4359-9634-0CC2F3204388Q51522548-DA4CC52D-3EEE-44BC-8E98-FC3FAA6383ECQ51798252-3E72CFDE-42E2-4947-8AE8-E78686EC8F59Q51891908-F3A8217B-7774-4EC0-9F2D-F1466B3E429A
P2860
Molecular lipophilicity in protein modeling and drug design.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Molecular lipophilicity in protein modeling and drug design.
@ast
Molecular lipophilicity in protein modeling and drug design.
@en
type
label
Molecular lipophilicity in protein modeling and drug design.
@ast
Molecular lipophilicity in protein modeling and drug design.
@en
prefLabel
Molecular lipophilicity in protein modeling and drug design.
@ast
Molecular lipophilicity in protein modeling and drug design.
@en
P2093
P1476
Molecular lipophilicity in protein modeling and drug design
@en
P2093
Alexander S Arseniev
Edgar Jacoby
John P Priestle
Roman G Efremov
Timothy V Pyrkov
P304
P356
10.2174/092986707779941050
P577
2007-01-01T00:00:00Z